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low SAFV detection rate remains 
thereby diffi cult to explain. 
The outcome can be explained 
by a short duration of virus excretion 
in stool, which, however, is unlikely 
for an infection spreading by the 
fecal–oral route. Alternatively, it may 
be that the virus is unstable in stool 
and rapidly degrades, such that fecal 
samples are inadequate for diagnosis 
of the infection. Other specimens, 
however, such as respiratory samples, 
yielded also low numbers of positive 
fi ndings (4). Remarkably, the study 
with a high prevalence of positive 
stool samples made use of primers 
selected in a conserved region of 2C 
helicase (5), whereas other studies 
used primers in the 5′ noncoding 
region (3,4). Hence, a difference in 
sensitivity between the different PCRs 
may be responsible for the discrepancy 
between seroepidemiology and the 
low diagnostic yield by PCR. This 
discrepancy, however, awaits further 
investigation.
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Alkhurma 
Hemorrhagic Fever 
in Travelers 
Returning from 
Egypt, 2010
To the Editor: The report of 2 
visitors from Italy being infected by 
Alkhurma hemorrhagic fever virus 
(AHFV) in southeastern Egypt near 
the border with Sudan (1) provides 
useful data to help clarify the 
evolutionary origin of these tick-borne 
fl aviviruses. AHFV was fi rst isolated 
in Saudi Arabia and is associated with 
camel ticks (2). It is a genetically close 
relative of Kyasanur Forest disease 
virus, which was fi rst isolated in 
India in 1957. Following the original 
isolation of Kyasanur Forest disease 
virus, there was no clear explanation 
for its apparent isolation in the 
Indian forests. Indeed, its subsequent 
discovery in southern China (3) 
suggested that migratory birds might 
carry the infected ticks to or from that 
region.
The most likely explanation 
for these outbreaks of hemorrhagic 
disease now begins to fi t a pattern 
that can be interpreted in terms of the 
diseases’ evolutionary origin in Africa. 
Thousands of animals are annually 
transported from Africa and other 
countries to Mecca, Saudi Arabia, to 
meet the human demand for food and 
transport during the Hajj. Many of these 
animals, including camels, are infested 
with ticks that may carry AHFV 
and thus provide the source of this 
human infectious agent. Phylogenetic 
evidence had previously suggested that 
the tick-borne encephalitic fl avivirus 
serocomplex originated in Africa 
and gradually evolved and dispersed 
across the Northern Hemisphere of 
the Old World (4,5). This concept is 
totally consistent with the discoveries 
of AHFV in Saudi Arabia and now in 
southeastern Egypt. Thus, Africa is 
a likely source of infected ticks that 
are regularly moved between Africa 
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and Saudi Arabia. This concept of an 
African evolutionary origin for these 
viruses could readily be tested by 
serologic investigation of humans and 
animals and also by analysis of ticks 
from this region of Africa.
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In Response: The concept 
suggested by Charrel and Gould (1) 
of an African evolutionary origin 
for these tick-borne fl aviviruses and 
their dispersal across the Northern 
Hemisphere raises concerns over 
possible spread of a new potentially 
dangerous infection outside its country 
of origin. This awareness should 
alert physicians in Western countries 
to pathogens that cause unspecifi c, 
unusual, or totally unknown clinical 
signs. We agree that more research 
is needed in human and animal 
health, as well as in entomologic and 
environmental studies, especially in 
light of the recent data suggesting a 
nonexclusive role of ticks as vectors 
for human infection with Alkhurma 
virus and the hypothesis of human-to-
human transmission (2).
Past experience with emerging 
diseases in travelers (Crimean-Congo 
hemorrhagic fever, Lassa fever, 
Marburg hemorrhagic fever) or with 
autochthonous spread of imported 
diseases (chikungunya, West Nile 
virus disease, malaria) indicates a 
consistent delay in the diagnosis of 
fi rst or sporadic cases, leading to 
inappropriate or untimely treatment 
of some of the patients. To confront 
the problem of unusual and emerging 
pathogens, Western countries 
must invest in evidence-based and 
integrated strategies of preparedness 
and response.  
First, the frontline physicians’ 
ability to recognize, diagnose, and 
treat illnesses caused by unusual 
pathogens should be improved through 
training covering rare and tropical 
diseases. Second, a system of timely 
information and alerts about threats 
posed by new infectious diseases 
should be set up. Third, concentrating 
clinical samples in virology 
laboratories with proven experience 
in detecting emerging pathogens is 
crucial for comprehensive and rapid 
differential diagnosis. It must be also 
remembered that no commercial tests 
are available for serologic or molecular 
detection of many rare pathogens or 
for differential diagnosis. And, fi nally, 
laboratory diagnosis is often made 
diffi cult by antibody cross-reactivity, 
as documented in our article (3).
For Alkhurma virus, further 
research is needed in the animal 
setting because little is known about 
length and severity of illness, duration 
of viremia, and modes of animal-
to-animal and animal-to-human 
transmission; we need to better 
understand the role of vectors to limit 
the spread of the disease. 
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